Citations (111)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Sofia Lesica, Reid Skeel & Brittany Fust. (2023) The parent-reported ADHD symptom infrequency scale (PRASIS): a parent report measure of ADHD symptom exaggeration. Child Neuropsychology 29:2, pages 255-275.
Read now
Read now
Ann C. Childress, Nathalie Beltran, Carl Supnet & Margaret D. Weiss. (2021) Reviewing the role of emerging therapies in the ADHD armamentarium. Expert Opinion on Emerging Drugs 26:1, pages 1-16.
Read now
Read now
Bianca de Oliveira Cata Preta, Vanessa Iribarrem Avena Miranda & Andréa Dâmaso Bertoldi. (2020) Psychostimulant Use for Neuroenhancement (Smart Drugs) among College Students in Brazil. Substance Use & Misuse 55:4, pages 613-621.
Read now
Read now
David B Clemow, Chris Bushe, Michele Mancini, Michael H Ossipov & Himanshu Upadhyaya. (2017) A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities. Neuropsychiatric Disease and Treatment 13, pages 357-371.
Read now
Read now
Rakesh Jain & Jeffrey G. Stark. (2016) Safety and efficacy considerations due to misuse of extended-release formulations of stimulant medications. Postgraduate Medicine 128:7, pages 672-681.
Read now
Read now
Benchalak Maneeton, Narong Maneeton, Surinporn Likhitsathian, Sirijit Suttajit, Assawin Narkpongphun, Manit Srisurapanont & Pakapan Woottiluk. (2015) Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials. Drug Design, Development and Therapy 9, pages 1927-1936.
Read now
Read now
Daniel J Walker, Oren Mason, David B Clemow & Kathleen A Day. (2015) Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder. Postgraduate Medicine 127:7, pages 686-701.
Read now
Read now
Articles from other publishers (104)
Trent D. Emerick, Thomas J. MartinDouglas G. Ririe. (2023) Perioperative Considerations for Patients Exposed to Psychostimulants. Anesthesia & Analgesia 137:3, pages 474-487.
Crossref
Crossref
Paul L. Morgan, Adrienne D. Woods & Yangyang Wang. (2022) Sociodemographic Disparities in Attention-Deficit/Hyperactivity Disorder Overdiagnosis and Overtreatment During Elementary School. Journal of Learning Disabilities 56:5, pages 359-370.
Crossref
Crossref
Nicole Mauche, Christine Ulke, Jue Huang, Annegret Franke, Holger Bogatsch, Thomas Ethofer, Oliver Grimm, Thomas Frodl, Knut Hoffmann, Georg Juckel, Sarah Kittel-Schneider, Aylin Mehren, Alexandra Philipsen, Christian Plewnia, Andreas Reif, Georg C. Ziegler & Maria Strauß. (2023) Treatment of adult attention-deficit hyperactivity disorder (ADHD) with transcranial direct current stimulation (tDCS): study protocol for a parallel, randomized, double-blinded, sham-controlled, multicenter trial (Stim-ADHD). European Archives of Psychiatry and Clinical Neuroscience.
Crossref
Crossref
Namkee G. Choi, Bryan Y. Choi & S. David Baker. (2023) Suspected Suicide Attempt and Intentional Misuse Cases Aged 50+ Involving Amphetamine or Methylphenidate and Medical Outcomes: Associations with Co-Used Other Substances. Pharmacoepidemiology 2:3, pages 236-248.
Crossref
Crossref
Riku Arakawa, Karan Ahuja, Kristie Mak, Gwendolyn Thompson, Sam Shaaban, Oliver Lindhiem & Mayank Goel. (2023) LemurDx. Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies 7:2, pages 1-23.
Crossref
Crossref
Satoshi Kasahara, Yuichi Kato, Kaori Takahashi, Ko Matsudaira, Naoko Sato, Ken‐Ichi Fukuda, Akira Toyofuku, Shin‐Ichi Niwa & Kanji Uchida. (2023)
Improvement in persistent idiopathic facial pain with comorbid
ADHD
using the combination of a dopamine system stabilizer and psychostimulant: A case report
. Clinical Case Reports 11:6.
Crossref
Crossref
Alisa R. Kosheleff, Oren Mason, Rakesh Jain, Jennifer Koch & Jonathan Rubin. (2023) Functional Impairments Associated With ADHD in Adulthood and the Impact of Pharmacological Treatment. Journal of Attention Disorders 27:7, pages 669-697.
Crossref
Crossref
Sean Esteban McCabe, Olivia Figueroa, Vita V. McCabe, Ty S. Schepis, John E. Schulenberg, Philip T. Veliz, Kennedy S. Werner & Timothy E. Wilens. (2023) Is age of onset and duration of stimulant therapy for ADHD associated with cocaine, methamphetamine, and prescription stimulant misuse?. Journal of Child Psychology and Psychiatry.
Crossref
Crossref
Arjun Chatterjee, Alejandro Duran Crane, Caroline Olt & Marina Freiberg. (2023) Transient Right Ventricular Failure from Intravenous Injection of Methylphenidate Tablets. Journal of Brown Hospital Medicine 2:2.
Crossref
Crossref
F. V. Ryzhkov, Y. E. Ryzhkova, M. N. Elinson & M. P. Egorov. (2023) Modern synthesis of cognitive enhancers: cholinergic ligands. Russian Chemical Bulletin 72:4, pages 819-837.
Crossref
Crossref
Ole Jakob Storebø, Maja Rosenberg Overby Storm, Johanne Pereira Ribeiro, Maria Skoog, Camilla Groth, Henriette E Callesen, Julie Perrine Schaug, Pernille Darling Rasmussen, Christel-Mie L Huus, Morris Zwi, Richard Kirubakaran, Erik Simonsen & Christian Gluud. (2023) Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database of Systematic Reviews 2023:3.
Crossref
Crossref
Anthony Yuan, Natasha Kharas, Nicholas King, Pamela Yang & Nachum Dafny. (2023) Methylphenidate cross-sensitization with amphetamine is dose dependent but not age dependent. Behavioural Brain Research 438, pages 114178.
Crossref
Crossref
Suzanne K. Vosburg, Stephen V. Faraone, Elizabeth Riley, Timothy Whitaker, Jessica Kardish, David Baker, Scott H. Kollins & Craig R. Rush. (2022) Intranasal Use of Prescription Stimulants Among Adults Aged 18 to 30: Results From A Crowdsourcing Platform. Journal of Attention Disorders 27:1, pages 14-25.
Crossref
Crossref
Johnny L. Matson. 2023. Clinical Handbook of ADHD Assessment and Treatment Across the Lifespan. Clinical Handbook of ADHD Assessment and Treatment Across the Lifespan
649
658
.
Sujith Ramachandran, Jeffrey M. Pavlacic, John Young & John P. Bentley. 2023. Clinical Handbook of ADHD Assessment and Treatment Across the Lifespan. Clinical Handbook of ADHD Assessment and Treatment Across the Lifespan
277
293
.
Jenny Berezanskaya, William Cade, Thomas M. Best, Kristopher Paultre & Carolyn Kienstra. (2022) ADHD Prescription Medications and Their Effect on Athletic Performance: A Systematic Review and Meta-analysis. Sports Medicine - Open 8:1.
Crossref
Crossref
Samuel Obeng, Francisco Leon, Avi Patel, Julio D. Zuarth Gonzalez, Lucas Chaves Da Silva, Luis F. Restrepo, Lea R. Gamez-Jimenez, Nicholas P. Ho, Maria P. Guerrero Calvache, Victoria L.C. Pallares, Justin A. Helmes, Sakura K. Shiomitsu, Paul L. Soto, Aidan J. Hampson, Christopher R. McCurdy, Lance R. McMahon, Jenny L. Wilkerson & Takato Hiranita. (2022)
Interactive Effects of
µ
-Opioid and Adrenergic-
α
2
Receptor Agonists in Rats: Pharmacological Investigation of the Primary Kratom Alkaloid Mitragynine and Its Metabolite 7-Hydroxymitragynine
. Journal of Pharmacology and Experimental Therapeutics 383:3, pages 182-198.
Crossref
Crossref
Victoria A. Nazarova, Aleksandr V. Sokolov, Vladimir N. Chubarev, Vadim V. Tarasov & Helgi B. Schiöth. (2022) Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials. Frontiers in Pharmacology 13.
Crossref
Crossref
Ana Clara da Costa Nunes Gomes, Camila Souza Bellin, Stephanie da Silva Dias, Thalita de Queiroz de Rosa, Marina Pereira de Araújo, Sandra Maria Miraglia, Talita Biude Mendes & Vanessa Vendramini. (2022) Increased sperm deoxyribonucleic acid damage leads to poor embryo quality and subfertility of male rats treated with methylphenidate hydrochloride in adolescence. Andrology 10:8, pages 1632-1643.
Crossref
Crossref
Mitchell Schertz, Yael Karni-Visel, Jacob Genizi, Hofit Manishevitch, Menachem Lam, Ashraf Akawi, Michal Dudai, André A Fenton & Marom Bikson. (2022) Transcranial Direct Current Stimulation (tDCS) in children with ADHD: A randomized, sham-controlled pilot study. Journal of Psychiatric Research 155, pages 302-312.
Crossref
Crossref
Enrico Capuzzi, Alice Caldiroli, Anna Maria Auxilia, Riccardo Borgonovo, Martina Capellazzi, Massimo Clerici & Massimiliano Buoli. (2022) Biological Predictors of Treatment Response in Adult Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review. Journal of Personalized Medicine 12:10, pages 1742.
Crossref
Crossref
Joseph Sadek. (2022) Malingering and Stimulant Medications Abuse, Misuse and Diversion. Brain Sciences 12:8, pages 1004.
Crossref
Crossref
Anne Mette Skov Sørensen, Rikke Wesselhöft, Jacob Harbo Andersen, Johan Reutfors, Carolyn E. Cesta, Kari Furu, Ingeborg Hartz & Lotte Rasmussen. (2022) Trends in use of attention deficit hyperactivity disorder medication among children and adolescents in Scandinavia in 2010–2020. European Child & Adolescent Psychiatry.
Crossref
Crossref
Wanalee Klomjai, Vorasith Siripornpanich, Benchaporn Aneksan, Oranich Vimolratana, Kannika Permpoonputtana, Jarugool Tretriluxana & Peeradech Thichanpiang. (2022) Effects of cathodal transcranial direct current stimulation on inhibitory and attention control in children and adolescents with attention-deficit hyperactivity disorder: A pilot randomized sham-controlled crossover study. Journal of Psychiatric Research 150, pages 130-141.
Crossref
Crossref
Yoosuk An, Yoojin Song & Ung Gu Kang. (2022) A Conceptual Review on ADHD and Adult ADHD (2): Psychopathology, Diagnostic and Therapeutic Implications of ADHD. Journal of Korean Neuropsychiatric Association 61:2, pages 45.
Crossref
Crossref
Julie Sarno Owens, Chelsea L. Hustus, Elise L. Everly, Steven W. Evans & Samantha M. Margherio. 2022. Comprehensive Clinical Psychology. Comprehensive Clinical Psychology
395
411
.
Kimberley Levitt & Barbara Felt. 2022. Symptom-Based Approach to Pediatric Neurology. Symptom-Based Approach to Pediatric Neurology
67
80
.
Melissa R. Schick, Tessa Nalven, Michael C. Crawford, Katelyn T. Kirk-Provencher & Nichea S. Spillane. 2022. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions
161
185
.
J. J. Sandra KooijJ. J. Sandra Kooij. 2022. Adult ADHD. Adult ADHD
87
149
.
Melissa R. Schick, Tessa Nalven, Michael C. Crawford, Katelyn T. Kirk-Provencher & Nichea S. Spillane. 2021. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions
1
25
.
Manas K. Akmatov, Jakob Holstiege & Jörg Bätzing. (2021) Secular trends and regional variations in pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) among children and adolescents in Germany. BMC Psychiatry 21:1.
Crossref
Crossref
Linda B. Cottler, Sonam O. Lasopa, Catherine W. Striley, Theodore J. Cicero, Nicole D. Fitzgerald & Arbi Ben Abdallah. (2021) Prescription stimulant brand name recognition among a national sample of 10‐ to 18‐year‐old youth. International Journal of Methods in Psychiatric Research 30:4.
Crossref
Crossref
Stephen F. Butler, Stephen V. Faraone, Anthony L. Rostain, Jeffrey H. Newcorn, Kevin M. Antshel, Rebekkah S. Robbins & Jody L. Green. (2021) Non-medical Use of Prescription Stimulants Among College Students: Non-oral Routes of Administration, Risk Factors, Motivations, and Pathways. Frontiers in Psychiatry 12.
Crossref
Crossref
Azmi Nasser, Alisa R. Kosheleff, Joseph T. Hull, Tesfaye Liranso, Peibing Qin, Gregory D. Busse, Maurizio Fava, Vladimir Maletic, Jonathan Rubin & Frank Lopez. (2021) Evaluating the likelihood to be helped or harmed after treatment with viloxazine extended‐release in children and adolescents with attention‐deficit/hyperactivity disorder. International Journal of Clinical Practice 75:8.
Crossref
Crossref
Nicole Hadler, Arianna Strome, Marika Waselewski, Kelsey Herbert, Chloe Harper & Tammy Chang. (2021) Perspectives of US Adolescents on Diverted Stimulant Use. The Journal of Pediatrics 235, pages 190-195.
Crossref
Crossref
Maurizio Bonati, Francesca Scarpellini, Massimo Cartabia & Michele Zanetti. (2021) Ten Years (2011–2021) of the Italian Lombardy ADHD Register for the Diagnosis and Treatment of Children and Adolescents with ADHD. Children 8:7, pages 598.
Crossref
Crossref
Robert L. Findling, Shawn A. Candler, Azmi F. Nasser, Stefan Schwabe, Chungping Yu, Jennie Garcia-Olivares, Welton O’Neal & Jeffrey H. Newcorn. (2021) Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status. CNS Drugs 35:6, pages 643-653.
Crossref
Crossref
Dian-Jeng Li, Yi-Lung Chen, Ray C. Hsiao, Hsiu-Lin Chen & Cheng-Fang Yen. (2021) Risk of Respiratory Infectious Diseases and the Role of Methylphenidate in Children with Attention-Deficit/Hyperactivity Disorder: A Population-Based Cohort Study. International Journal of Environmental Research and Public Health 18:11, pages 5824.
Crossref
Crossref
Trevor R. Buckley. (2019) Rates of Performance Validity Test Failure for ADHD Evaluations in a Military Population: An Exploratory Study. Journal of Attention Disorders 25:5, pages 685-692.
Crossref
Crossref
Shamia L. Faison, Nicholas Fry, Toyin Adewole, Oyinkansola Odebo, Zhao Wang, Vladimir MaleticAzmi Nasser. (2021) Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Lisdexamfetamine in Healthy Adults. Journal of Clinical Psychopharmacology 41:2, pages 155-162.
Crossref
Crossref
Sunsha Chamakalayil, Johannes Strasser, Marc Vogel, Serge Brand, Marc Walter & Kenneth M. Dürsteler. (2021) Methylphenidate for Attention-Deficit and Hyperactivity Disorder in Adult Patients With Substance Use Disorders: Good Clinical Practice. Frontiers in Psychiatry 11.
Crossref
Crossref
Suzanne K. Vosburg, Rebekkah S. Robbins, Kevin M. Antshel, Stephen V. Faraone & Jody L. Green. (2021) Characterizing Pathways of Non-oral Prescription Stimulant Non-medical Use Among Adults Recruited From Reddit. Frontiers in Psychiatry 11.
Crossref
Crossref
Bruno S. Subbarao & Blessen C. Eapen. 2021. Clinical Management of the Homeless Patient. Clinical Management of the Homeless Patient
103
121
.
Amy R. Board, Gery Guy, Christopher M. Jones & Brooke Hoots. (2020) Trends in stimulant dispensing by age, sex, state of residence, and prescriber specialty — United States, 2014–2019. Drug and Alcohol Dependence 217, pages 108297.
Crossref
Crossref
Kelly Bedard & Allison Witman. (2019) Family structure and the gender gap in ADHD. Review of Economics of the Household 18:4, pages 1101-1129.
Crossref
Crossref
Paul L. Soto & Takato Hiranita. (2020) Effects of benztropine analogs on delay discounting in rats. Psychopharmacology 237:12, pages 3783-3794.
Crossref
Crossref
Ki Yong Kim & Jeong-Eun Oh. (2020) Evaluation of pharmaceutical abuse and illicit drug use in South Korea by wastewater-based epidemiology. Journal of Hazardous Materials 396, pages 122622.
Crossref
Crossref
Lucas M. Donovan, Aditi Shah, Ching Li Chai-Coetzer, Ferran Barbé, Najib T. Ayas & Vishesh K. Kapur. (2020) Redesigning Care for OSA. Chest 157:4, pages 966-976.
Crossref
Crossref
Krista J. Siefried, Liam S. Acheson, Nicholas Lintzeris & Nadine Ezard. (2020) Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review. CNS Drugs 34:4, pages 337-365.
Crossref
Crossref
Steven CarasTerrilyn Sharpe. (2020) Pharmacokinetics of AR19, an Immediate-Release Amphetamine Sulfate Formulation Designed to Deter Manipulation for Administration Via Nonoral Routes: Bioequivalence to Reference Racemic Amphetamine Sulfate, Dose Proportionality, and Food Effect. Journal of Child and Adolescent Psychopharmacology 30:2, pages 69-80.
Crossref
Crossref
Zhengrong Xu & Qian Li. (2019) TAAR Agonists. Cellular and Molecular Neurobiology 40:2, pages 257-272.
Crossref
Crossref
Claudia van der Heijde, Carmel van den Berk & Peter Vonk. (2020) Ervaringen en visies van professionals over gebruik en misbruik van methylfenidaat door studenten in het hoger onderwijsExperiences and visions amongst professionals regarding the (ab)use of methylphenidate by higher educational students. TSG - Tijdschrift voor gezondheidswetenschappen 98:1, pages 1-8.
Crossref
Crossref
Stephen V. Faraone, Anthony L. Rostain, C. Brendan Montano, Oren Mason, Kevin M. Antshel & Jeffrey H. Newcorn. (2020) Systematic Review: Nonmedical Use of Prescription Stimulants: Risk Factors, Outcomes, and Risk Reduction Strategies. Journal of the American Academy of Child & Adolescent Psychiatry 59:1, pages 100-112.
Crossref
Crossref
Brooke S.G. Molina, Heidi L. Kipp, Heather M. Joseph, Stacey A. Engster, Seth C. Harty, Montaya Dawkins, Rachel A. Lindstrom, Daniel J. Bauer & Srihari S. Bangalore. (2020) Stimulant Diversion Risk Among College Students Treated for ADHD: Primary Care Provider Prevention Training. Academic Pediatrics 20:1, pages 119-127.
Crossref
Crossref
Christine Ulke, Michael Rullmann, Jue Huang, Julia Luthardt, Georg-Alexander Becker, Marianne Patt, Philipp M. Meyer, Solveig Tiepolt, Swen Hesse, Osama Sabri & Maria Strauß. (2019) Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[11C]methylreboxetine positron emission tomography study. Translational Psychiatry 9:1.
Crossref
Crossref
Kathleen T. McCoy, Kirsten Pancione, Linda Sue Hammonds & Christine B. Costa. (2019) Management of Attention-Deficit/Hyperactivity Disorder in Primary Care. Nursing Clinics of North America 54:4, pages 517-532.
Crossref
Crossref
Sara Dehbozorghi, Sayna Bagheri, Kamyar Moradi, Kamyar Shokraee, Mohammad‐Reza Mohammadi & Shahin Akhondzadeh. (2019) Efficacy and safety of tipepidine as adjunctive therapy in children with attention‐deficit/hyperactivity disorder: Randomized, double‐blind, placebo‐controlled clinical trial. Psychiatry and Clinical Neurosciences 73:11, pages 690-696.
Crossref
Crossref
Mario Ciocca. (2019) Attention Deficit Hyperactivity Disorder in Athletes. Clinics in Sports Medicine 38:4, pages 545-554.
Crossref
Crossref
Nicholas King, Samuel Floren, Natasha Kharas, Ming Thomas & Nachum Dafny. (2019) Glutaminergic signaling in the caudate nucleus is required for behavioral sensitization to methylphenidate. Pharmacology Biochemistry and Behavior 184, pages 172737.
Crossref
Crossref
Donald E. Greydanus, Kevin W. Cates & Nina Sadigh. (2019) Adverse effects of stimulant medications in children and adolescents: focus on drug abuse. International Journal of Adolescent Medicine and Health 31:4.
Crossref
Crossref
Jon E. Grant, Stephanie Valle, Elizabeth Cavic, Sarah A. Redden & Samuel R. Chamberlain. (2019) A double‐blind, placebo‐controlled study of vortioxetine in the treatment of binge‐eating disorder. International Journal of Eating Disorders 52:7, pages 786-794.
Crossref
Crossref
Daniel Eckernäs, Fredrik Hieronymus, Thomas Carlsson & Filip Bergquist. (2019) Acoustic white noise ameliorates reduced regional brain expression of CaMKII and ΔFosB in the spontaneously hypertensive rat model of ADHD. IBRO Reports 6, pages 31-39.
Crossref
Crossref
Florentia Kaguelidou, Geneviève Durrieu & Antonio Clavenna. (2019) Pharmacoepidemiological research for the development and evaluation of drugs in pediatrics. Therapies 74:2, pages 315-324.
Crossref
Crossref
Rachel L. Navarra & Barry D. Waterhouse. (2019) Considering noradrenergically mediated facilitation of sensory signal processing as a component of psychostimulant-induced performance enhancement. Brain Research 1709, pages 67-80.
Crossref
Crossref
Kamala D. Via. (2019) Preventing the Next Epidemic: Prescribed Stimulant Abuse. The Journal for Nurse Practitioners 15:3, pages 232-235.
Crossref
Crossref
Haggai Schermann, Ran Ankory, Amir Shlaifer, Oleg Dolkart, Dani Rotman, Vicky Yoffe, Isabella Karakis & Ofir Chechik. (2019) Lower risk of stress fractures in young adults with ADHD under chronic treatment with methylphenidate. Bone 120, pages 20-24.
Crossref
Crossref
Thomas A. Pickens, Sara P. Khan & Daniel J. Berlau. (2019) White noise as a possible therapeutic option for children with ADHD. Complementary Therapies in Medicine 42, pages 151-155.
Crossref
Crossref
Stephanie A. Ihezie, Ming M. Thomas & Nachum Dafny. (2019) Acute and chronic methylphenidate administration in intact and VTA-specific and nonspecific lesioned rats. Journal of Neural Transmission 126:2, pages 173-182.
Crossref
Crossref
Andreas G. Franke. 2019. Suchtmedizin. Suchtmedizin
397
405
.
Amber D. Hunt, David W. Dunn, Hillary S. Blake & Jennifer Downs. 2019. Treatment Resistance in Psychiatry. Treatment Resistance in Psychiatry
215
235
.
Andreas G. FrankeAndreas G. Franke. 2019. Hirndoping & Co.. Hirndoping & Co.
155
162
.
Joseph SadekJoseph Sadek. 2019. Clinician’s Guide to ADHD Comorbidities in Children and Adolescents. Clinician’s Guide to ADHD Comorbidities in Children and Adolescents
61
75
.
Anca M. Grecu, Dhaval M. Dave & Henry Saffer. (2018) Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse. Journal of Policy Analysis and Management 38:1, pages 181-209.
Crossref
Crossref
Jayne Lucke, Charmaine Jensen, Matthew Dunn, Gary Chan, Cynthia Forlini, Sharlene Kaye, Bradley Partridge, Michael Farrell, Eric Racine & Wayne Hall. (2018) Non-medical prescription stimulant use to improve academic performance among Australian university students: prevalence and correlates of use. BMC Public Health 18:1.
Crossref
Crossref
Haggai Schermann, Ron Gurel, Ran Ankory, Assaf Kadar, Victoria Yoffe, Nimrod Snir, Amir Sternheim & Isabella Karakis. (2018) Lower risk of fractures under methylphenidate treatment for ADHD: A dose–response effect. Journal of Orthopaedic Research 36:12, pages 3328-3333.
Crossref
Crossref
Ronit Shtrichman, Stefan Conrad, Kai Schimo, Ran Shachar, Ehud Machluf, Enrique Mindal, Howard Epstein, Shirli Epstein & Alan Paz. (2018) Use of a Digital Medication Management System for Effective Assessment and Enhancement of Patient Adherence to Therapy (ReX): Feasibility Study. JMIR Human Factors 5:4, pages e10128.
Crossref
Crossref
Mark E FeldmanAlice CharachStacey A Bélanger. (2018) Le TDAH chez les enfants et les adolescents, partie 2 : le traitement. Paediatrics & Child Health 23:7, pages 473-484.
Crossref
Crossref
Mark E Feldman, Alice Charach & Stacey A Bélanger. (2018) ADHD in children and youth: Part 2—Treatment. Paediatrics & Child Health 23:7, pages 462-472.
Crossref
Crossref
Ilan S. Ben-Ami, Ran Ankory, Assaf Kadar, Dani Rotman, Nimrod Snir & Haggai Schermann. (2018) The Effect of Previous Methylphenidate Use on Incidence of Stress Fractures in Military Recruits. Journal of Bone and Joint Surgery 100:11, pages 930-935.
Crossref
Crossref
Tim L. Wigal, Jeffrey H. Newcorn, Nelson Handal, Sharon B. Wigal, Ioulietta Mulligan, Virginia Schmith & Eric Konofal. (2018) A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD). CNS Drugs 32:3, pages 289-301.
Crossref
Crossref
Oliver Hirsch & Hanna Christiansen. (2015) Faking ADHD? Symptom Validity Testing and Its Relation to Self-Reported, Observer-Reported Symptoms, and Neuropsychological Measures of Attention in Adults With ADHD. Journal of Attention Disorders 22:3, pages 269-280.
Crossref
Crossref
Christina L. Zuch de Zafra, Carrie G. Markgraf, David R. Compton & Thomas J. Hudzik. (2018) Abuse liability assessment for biologic drugs – All molecules are not created equal. Regulatory Toxicology and Pharmacology 92, pages 165-172.
Crossref
Crossref
Pierre Beaulieu. (2017) Anesthetic implications of recreational drug useImplications anesthésiques de l’usage de drogues dans un but récréatif. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 64:12, pages 1236-1264.
Crossref
Crossref
Isabella J. M. Niesten, Wenke Müller, Harald Merckelbach, Brechje Dandachi-FitzGerald & Marko Jelicic. (2017) Moral Reminders Do Not Reduce Symptom Over-Reporting Tendencies. Psychological Injury and Law 10:4, pages 368-384.
Crossref
Crossref
Ana Causanilles, Juliet Kinyua, Christoph Ruttkies, Alexander L.N. van Nuijs, Erik Emke, Adrian Covaci & Pim de Voogt. (2017) Qualitative screening for new psychoactive substances in wastewater collected during a city festival using liquid chromatography coupled to high-resolution mass spectrometry. Chemosphere 184, pages 1186-1193.
Crossref
Crossref
Luc Zimmer. (2017) Contribution of Clinical Neuroimaging to the Understanding of the Pharmacology of Methylphenidate. Trends in Pharmacological Sciences 38:7, pages 608-620.
Crossref
Crossref
Michael Soyka & Andreas G. Franke. (2017) (Psycho-)Stimulanzien in Psychopharmakotherapie und pharmakologischem Neuroenhancement und ihre suchtmedizinischen Implikationen. SUCHT 63:3, pages 157-167.
Crossref
Crossref
Jose Martinez-Raga, Amparo Ferreros, Carlos Knecht, Raquel de Alvaro & Eloisa Carabal. (2016) Attention-deficit hyperactivity disorder medication use: factors involved in prescribing, safety aspects and outcomes. Therapeutic Advances in Drug Safety 8:3, pages 87-99.
Crossref
Crossref
Maximilian Gahr, Bernhard Connemann, Carlos Schönfeldt-Lecuona & René Zeiss. (2017) Sensitivity of Quantitative Signal Detection in Regards to Pharmacological Neuroenhancement. International Journal of Molecular Sciences 18:1, pages 101.
Crossref
Crossref
Joseph SadekJoseph Sadek. 2017. Clinician’s Guide to Adult ADHD Comorbidities. Clinician’s Guide to Adult ADHD Comorbidities
41
53
.
Joseph SadekJoseph Sadek. 2017. Clinician’s Guide to Adult ADHD Comorbidities. Clinician’s Guide to Adult ADHD Comorbidities
11
20
.
Linda Patia Spear. (2016) Consequences of adolescent use of alcohol and other drugs: Studies using rodent models. Neuroscience & Biobehavioral Reviews 70, pages 228-243.
Crossref
Crossref
Cody J. Wenthur. (2016) Classics in Chemical Neuroscience: Methylphenidate. ACS Chemical Neuroscience 7:8, pages 1030-1040.
Crossref
Crossref
Belen Rubio, Aaron D. Boes, Simon Laganiere, Alexander Rotenberg, Danique Jeurissen & Alvaro Pascual-Leone. (2015) Noninvasive Brain Stimulation in Pediatric Attention-Deficit Hyperactivity Disorder (ADHD). Journal of Child Neurology 31:6, pages 784-796.
Crossref
Crossref
Pernille WarrerPer Hove ThomsenSøren DalsgaardEbba Holme HansenLise AagaardHelle Wallach KildemoesHenrik Berg Rasmussen. (2016) Switch in Therapy from Methylphenidate to Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: An Analysis of Patient Records. Journal of Child and Adolescent Psychopharmacology 26:4, pages 354-361.
Crossref
Crossref
K.S. Koblan, S.C. Hopkins, K. Sarma, N. Gallina, F. Jin, N. Levy-Cooperman, K.A. Schoedel & A. Loebel. (2016) Assessment of human abuse potential of dasotraline compared to methylphenidate and placebo in recreational stimulant users. Drug and Alcohol Dependence 159, pages 26-34.
Crossref
Crossref
Disa Dahlman, Tove Abrahamsson, Alex H. Kral & Anders Hakansson. (2016) Nonmedical Use of Antihistaminergic Anxiolytics and Other Prescription Drugs among Persons with Opioid Dependence. Journal of Addiction 2016, pages 1-11.
Crossref
Crossref
David B Clemow & Chris J Bushe. (2015) Atomoxetine in patients with ADHD: A clinical and pharmacological review of the onset, trajectory, duration of response and implications for patients. Journal of Psychopharmacology 29:12, pages 1221-1230.
Crossref
Crossref
Samaneh Kabul, Carlos Alatorre, Leslie B. Montejano, Amanda M. Farr & David B. Clemow. (2015) Real‐World Dosing Patterns of Atomoxetine in Adults with Attention‐Deficit/Hyperactivity Disorder. CNS Neuroscience & Therapeutics 21:12, pages 936-942.
Crossref
Crossref
Rebeca Heidbreder. (2015) ADHD symptomatology is best conceptualized as a spectrum: a dimensional versus unitary approach to diagnosis. ADHD Attention Deficit and Hyperactivity Disorders 7:4, pages 249-269.
Crossref
Crossref
Hou Jiang-Hao, Hao Ying, Chen Xiao-Jing, Hao Zhen, Hou Jin-Jie & Liu Yu-Hong. (2015) Research Hotspots Analysis of Attention-Deficit/Hyperactivity Disorder by PubMed. Research Hotspots Analysis of Attention-Deficit/Hyperactivity Disorder by PubMed.
H. Burgos, C. Cofré, A. Hernández, P. Sáez-Briones, R. Agurto, A. Castillo, B. Morales & M.L. Zeise. (2015) Methylphenidate has long-lasting metaplastic effects in the prefrontal cortex of adolescent rats. Behavioural Brain Research 291, pages 112-117.
Crossref
Crossref
Sonam O. Lasopa, Catherine W. Striley & Linda B. Cottler. (2015) Diversion of prescription stimulant drugs among 10–18-year-olds. Current Opinion in Psychiatry 28:4, pages 292-298.
Crossref
Crossref
David B. Clemow. 2017. Non-medical and illicit use of psychoactive drugs. Non-medical and illicit use of psychoactive drugs
99
124
.